CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-25 | Karlin Dan Chief Medical Officer | Sale | −8,242 | $0.77 | $6K | 4,087,274 |
| 2022-05-23 | Greenway Schond L. Chief Financial Officer | Grant or award | +1,270,000 | 1,270,000 | ||
| 2022-05-23 | Greenway Schond L. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | ||
| 2022-05-23 | Greenway Schond L. Chief Financial Officer | Grant or award | +1,270,000 | 1,270,000 | ||
| 2022-05-23 | Greenway Schond L. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | ||
| 2022-05-18 | Barrow Robert Chief Executive Officer | Sale | −18,948 | $0.71 | $13K | 3,995,309 |
| 2022-05-15 | Barrow Robert Chief Executive Officer | Shares withheld for taxes | −18,948 | $0.82 | $16K | 3,995,309 |
| 2022-05-11 | Makes Brigid Director | Other acquisition | +67,678 | 94,050 | ||
| 2022-04-26 | Karlin Dan Chief Medical Officer | Shares withheld for taxes | −13,038 | $0.81 | $11K | 4,095,516 |
| 2022-04-18 | Barrow Robert Chief Executive Officer | Shares withheld for taxes | −19,110 | $0.92 | $18K | 4,014,257 |
| 2022-03-28 | Karlin Dan Chief Medical Officer | Shares withheld for taxes | −10,203 | $1.17 | $12K | 4,108,554 |
| 2022-03-24 | Hu Cynthia W. Chief Legal Officer&Secretary | Grant or award | +1,200,000 | 1,200,000 | ||
| 2022-03-24 | Hu Cynthia W. Chief Legal Officer&Secretary | Grant or award · Stock Option (Right to Buy) | +1,560,000 | 1,560,000 | ||
| 2022-03-24 | Wernli Miri Halperin Executive President | Grant or award | +600,000 | 1,275,000 | ||
| 2022-03-24 | Wernli Miri Halperin Executive President | Grant or award · Stock Option (Right to Buy) | +780,000 | 4,462,500 | ||
| 2022-03-24 | Karlin Dan Chief Medical Officer | Grant or award | +950,000 | 4,118,757 | ||
| 2022-03-24 | Karlin Dan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +1,250,000 | 2,719,000 | ||
| 2022-03-24 | Barrow Robert Chief Executive Officer | Grant or award | +1,820,000 | 4,033,367 | ||
| 2022-03-24 | Barrow Robert Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,910,000 | 6,425,500 | ||
| 2022-03-15 | Barrow Robert Chief Executive Officer | Shares withheld for taxes | −12,612 | $1.00 | $13K | 2,213,367 |
Page 11 of 12 · 225 trades